InsidersTradesSigma
Follow the OPTHEA LIMITED stock price and the full management transaction log of the company, a listed issuer based in Australia. Shares are quoted on AU AU, under the authority of ASX. Market capitalisation: €19.2m. The latest transaction was disclosed on 22 June 2026 (Cease Substantial Holding). Among the most active insiders: 129 188 450 REGAL PARTNERS LIMITED. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
OPTHEA LIMITED is a company listed on the XASX, focused on developing treatments for eye diseases. It emphasizes innovation in the field of visual health.